Acta Ophthalmol
- LINDBOE JB, Brynskov T, Sorensen TL, Schmidt Laugesen C, et al
Real-world experiences with intravitreal treatment with ranibizumab and
aflibercept for diabetic macular oedema 2008-2021.
Acta Ophthalmol. 2024 Mar 25. doi: 10.1111/aos.16677.
- HELOTERA H, Arffman M, Sund R, Keskimaki I, et al
The incidence and prevalence of diabetic macular edema and proliferative diabetic
retinopathy, their progression to visual impairment and patterns in their
intravitreal treatment in the Finnish population.
Acta Ophthalmol. 2024 Mar 24. doi: 10.1111/aos.16675.
Am J Cardiol
- AGARWAL S, Qamar U, Fujiwara Y, Guha A, et al
The Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Cardiovascular
Outcomes in Patients with Cancer: A Systematic Review and Meta-Analysis.
Am J Cardiol. 2024 Feb 17:S0002-9149(24)00101.
- PERERA S, Zheng Z, Wadhera R
Cardiovascular Health, Lifestyle Factors, and Social Determinants Among Asian
Sub-Populations in the US.
Am J Cardiol. 2024 Feb 16:S0002-9149(24)00098.
Ann Intern Med
- GARABEDIAN LF, Zhang F, Costa R, Argetsinger S, et al
Association of State Insulin Out-of-Pocket Caps With Insulin Cost-Sharing and Use
Among Commercially Insured Patients With Diabetes : A Pre-Post Study With a
Control Group.
Ann Intern Med. 2024 Mar 26. doi: 10.7326/M23-1965.
Biochem Biophys Res Commun
- LUO X, Luan C, Zhou J, Ye Y, et al
Glycolytic enzyme Enolase-1 regulates insulin gene expression in pancreatic
beta-cell.
Biochem Biophys Res Commun. 2024;706:149735.
BMJ
- CHRISTIE B
Charity calls for Scottish government to increase access to diabetes technology.
BMJ. 2024;384:q755.
- MAHASE E
Type 1 diabetes: Randox removes adverts after claims that it was using fear to
sell genetic test.
BMJ. 2024;384:q744.
Diabetes
- ABRAHAM A, Cule M, Thanaj M, Basty N, et al
Genetic evidence for distinct biological mechanisms that link adiposity to type 2
diabetes: towards precision medicine.
Diabetes. 2024 Mar 26:db231005. doi: 10.2337/db23-1005.
- WILLIAMS RC, Hanson RL, Peters B, Kearns K, et al
Epistasis Between HLA-DRB1*16:02:01 and SLC16A11 T-C-G-T-T Reduces Odds for Type
2 Diabetes in Southwest American Indians.
Diabetes. 2024 Mar 26:db230925. doi: 10.2337/db23-0925.
- FAWAZ S, Martin Alonso A, Qiu Y, Ramnath R, et al
Adiponectin reduces glomerular endothelial glycocalyx disruption and restores
glomerular barrier function in a mouse model of type 2 diabetes.
Diabetes. 2024 Mar 26:db230455. doi: 10.2337/db23-0455.
Diabetes Care
- GARVEY WT, Cohen RM, Butera NM, Kazemi EJ, et al
Association of Baseline Factors With Glycemic Outcomes in GRADE: A Comparative
Effectiveness Randomized Clinical Trial.
Diabetes Care. 2024;47:562-570.
- FOSS-FREITAS MC, Imam S, Neidert A, Gomes AD, et al
Efficacy and Safety of Glucagon-Like Peptide 1 Agonists in a Retrospective Study
of Patients With Familial Partial Lipodystrophy.
Diabetes Care. 2024;47:653-659.
- AL RIFAI M, Al-Mallah MH, Blaha MJ, Patel J, et al
Epidemiology and Prognostic Implications of Coronary Artery Calcium in
Asymptomatic Individuals With Prediabetes: A Multicohort Study.
Diabetes Care. 2024;47:698-706.
- ANTHONY MS, Aroda VR, Parlett LE, Djebarri L, et al
Risk of Anaphylaxis Among New Users of GLP-1 Receptor Agonists: A Cohort Study.
Diabetes Care. 2024;47:712-719.
- WEISSMAN YL, Calvarysky B, Shochat T, Korotkov Z, et al
Disparities in Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor Prescription and
Dispensing in the Israeli Population-A Retrospective Cohort Study.
Diabetes Care. 2024;47:692-697.
- YUAN CY, Kong YW, Amoore T, Brown K, et al
Improved Satisfaction While Maintaining Safety and High Time in Range (TIR) With
a Medtronic Investigational Enhanced Advanced Hybrid Closed-Loop (e-AHCL) System.
Diabetes Care. 2024;47:747-755.
- CALIFF RM
Erratum. Our National Approach to Diabetes. Diabetes Care 2023;46:252-254.
Diabetes Care. 2024 Mar 22:dc24er05b. doi: 10.2337.
- LORBER DL, ElSayed NA, Bannuru RR, Shah V, et al
Diabetes Management in Detention Facilities: A Statement of the American Diabetes
Association.
Diabetes Care. 2024;47:544-555.
- NINON F, Alice L, Marie-Amelie BM, Laurence B, et al
Comment on Umapathysivam et al. Euglycemic Ketoacidosis in Two Patients Without
Diabetes After Introduction of Sodium-Glucose Cotransporter 2 Inhibitor for Heart
Failure With Reduced Ejection Fraction. Diabetes Care 2024;47:140-143.
Diabetes Care. 2024;47:e35.
- MALTESE G, Sinclair AJ
Comment on Kutz et al. Comparative Cardiovascular Effectiveness and Safety of
SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors According to
Frailty in Type 2 Diabetes. Diabetes Care 2023;46:2004-2014.
Diabetes Care. 2024;47:e32-e33.
- ST-ONGE MP, Zuraikat FM, Laferrere B, Jelic S, et al
Response to Comment on Zuraikat et al. Chronic Insufficient Sleep in Women
Impairs Insulin Sensitivity Independent of Adiposity Changes: Results of a
Randomized Trial. Diabetes Care 2024;47:117-125.
Diabetes Care. 2024;47:e37-e38.
- PAGE B
About the Editor: Camille E. Powe, MD: Advancing Research for Diabetes and
Pregnancy.
Diabetes Care. 2024;47:518-519.
- KAWADA T
Comment on Zuraikat et al. Chronic Insufficient Sleep in Women Impairs Insulin
Sensitivity Independent of Adiposity Changes: Results of a Randomized Trial.
Diabetes Care 2024;47:117-125.
Diabetes Care. 2024;47:e36.
- NAKASONE Y, Yamashita K, Aizawa T
Comment on Umapathysivam et al. Euglycemic Ketoacidosis in Two Patients Without
Diabetes After Introduction of Sodium-Glucose Cotransporter 2 Inhibitor for Heart
Failure With Reduced Ejection Fraction. Diabetes Care 2024;47:140-143.
Diabetes Care. 2024;47:e34.
- RIDDLE MC
Individualizing Treatment of Type 2 Diabetes After Metformin: More Insights From
GRADE.
Diabetes Care. 2024;47:556-561.
- JACOBSEN LM
Prompt Recognition of New-Onset Type 1 Diabetes Is Everyone's Responsibility-Even
on Weekends.
Diabetes Care. 2024;47:646-648.
- GIORGINO F, Franco DR, Nicolay C, Hemmingway A, et al
Effects of Tirzepatide Versus Basal Insulins in People With Type 2 Diabetes and
Different Baseline Glycemic Patterns: Post Hoc Analyses of the SURPASS-3 and
SURPASS-4 Trials.
Diabetes Care. 2024 Mar 26:dc232366. doi: 10.2337/dc23-2366.
- NAGEL KE, Ramachandran R, Lipska KJ
Lessons From Insulin: Policy Prescriptions for Affordable Diabetes and Obesity
Medications.
Diabetes Care. 2024 Mar 27:dci230042. doi: 10.2337/dci23-0042.
- ORLANDO G, Brown S, Jude E, Bowling FL, et al
Acute Effects of Vibrating Insoles on Dynamic Balance and Gait Quality in
Individuals With Diabetic Peripheral Neuropathy: A Randomized Crossover Study.
Diabetes Care. 2024 Mar 27:dc231858. doi: 10.2337/dc23-1858.
Diabetes Obes Metab
- TOMLINSON JW
Bardet-Biedl syndrome: A focus on genetics, mechanisms and metabolic dysfunction.
Diabetes Obes Metab. 2024;26 Suppl 2:13-24.
- ZHANG Y, Yang D, Jia Q, Yan J, et al
The effect of glucagon-like peptide-1 receptor agonists on cardiac function and
structure in patients with or without type 2 diabetes mellitus: An updated
systematic review and meta-analysis.
Diabetes Obes Metab. 2024 Mar 26. doi: 10.1111/dom.15557.
- CARIOU B, Linge J, Neeland IJ, Dahlqvist Leinhard O, et al
Effect of tirzepatide on body fat distribution pattern in people with type 2
diabetes.
Diabetes Obes Metab. 2024 Mar 26. doi: 10.1111/dom.15566.
- SUZUKI Y, Kaneko H, Nagasawa H, Okada A, et al
Comparison of estimated glomerular filtration rate change with sodium-glucose
cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists among
people with diabetes: A propensity-score matching study.
Diabetes Obes Metab. 2024 Mar 26. doi: 10.1111/dom.15561.
-
Correction to 'In people with type 2 diabetes, sarcopenia is associated with the
incidence of cardiovascular disease: A prospective cohort study from the UK
Biobank'.
Diabetes Obes Metab. 2024 Mar 27. doi: 10.1111/dom.15591.
Diabetologia
- MARCOVECCHIO ML, Hendriks AEJ, Delfin C, Battelino T, et al
The INNODIA Type 1 Diabetes Natural History Study: a European cohort of newly
diagnosed children, adolescents and adults.
Diabetologia. 2024 Mar 22. doi: 10.1007/s00125-024-06124.
- VAN DEN BURG EL, Schoonakker MP, van Peet PG, van den Akker-van Marle EM, et al
Integration of a fasting-mimicking diet programme in primary care for type 2
diabetes reduces the need for medication and improves glycaemic control: a
12-month randomised controlled trial.
Diabetologia. 2024 Mar 28. doi: 10.1007/s00125-024-06137.
- KORNUM DS, Bertoli D, Kufaishi H, Wegeberg AM, et al
Transcutaneous vagal nerve stimulation for treating gastrointestinal symptoms in
individuals with diabetes: a randomised, double-blind, sham-controlled,
multicentre trial.
Diabetologia. 2024 Mar 28. doi: 10.1007/s00125-024-06129.
Eur J Endocrinol
- AHN HY, Lee J, Kang J, Lee EK, et al
Increased risk of diabetes mellitus and hyperlipidemia in patients with
differentiated thyroid cancer.
Eur J Endocrinol. 2024;190:248-255.
Invest Ophthalmol Vis Sci
- MCCURRY CM, Sunilkumar S, Subrahmanian SM, Yerlikaya EI, et al
NLRP3 Inflammasome Priming in the Retina of Diabetic Mice Requires
REDD1-Dependent Activation of GSK3beta.
Invest Ophthalmol Vis Sci. 2024;65:34.
- GAO N, Yu FS
Lack of Elevated Expression of TGFbeta3 Contributes to the Delay of Epithelial Wound
Healing in Diabetic Corneas.
Invest Ophthalmol Vis Sci. 2024;65:35.
J Clin Endocrinol Metab
- QIU Z, Lee DH, Lu Q, Li R, et al
Associations of Regional Body Fat with Risk of Cardiovascular Disease and
Mortality among Individuals with Type 2 Diabetes.
J Clin Endocrinol Metab. 2024 Mar 26:dgae192. doi: 10.1210.
- LIU JJ, Liu S, Zheng H, Lee J, et al
Urine tricarboxylic acid cycle metabolites and risk of end stage kidney disease
in patients with type 2 diabetes.
J Clin Endocrinol Metab. 2024 Mar 28:dgae199. doi: 10.1210.
JAMA
- MOZAFFARIAN D
GLP-1 Agonists for Obesity-A New Recipe for Success?
JAMA. 2024;331:1007-1008.
PLoS One
- ZHANG F, Chen X, Yang M, Shen X, et al
Metabolic impairments associated with type 2 diabetes mellitus and the potential
effects of exercise therapy: An exploratory randomized trial based on untargeted
metabolomics.
PLoS One. 2024;19:e0300593.
- YANG J, Wang G, Xiao X, Bao M, et al
Explainable ensemble learning method for OCT detection with transfer learning.
PLoS One. 2024;19:e0296175.
- BRNABIC AJM, Curtis SE, Johnston JA, Lo A, et al
Incidence of type 2 diabetes, cardiovascular disease and chronic kidney disease
in patients with multiple sclerosis initiating disease-modifying therapies:
Retrospective cohort study using a frequentist model averaging statistical
framework.
PLoS One. 2024;19:e0300708.
- BORAI A, Ichihara K, Bahijri S, Alsofyani A, et al
Establishment of reference interval for hemoglobin A1C and other hemoglobin
subfractions for healthy Saudi adults.
PLoS One. 2024;19:e0300028.
- ABEBE MG, Alemayehu AM, Munaw MB, Tilahun MM, et al
Prevalence and associated factors of refractive error among adults in South
Ethiopia, a community-based cross-sectional study.
PLoS One. 2024;19:e0298960.
- MIHEVC M, Mirosevic S, Lukancic MM, Potocnik TV, et al
Assessing the reliability and validity of the Slovenian version of the Appraisal
of Diabetes Scale (ADS-S) in type 2 diabetes patients.
PLoS One. 2024;19:e0300797.
- GUO H, Zhang L, He H, Wang L, et al
Risk factors for catheter-associated bloodstream infection in hemodialysis
patients: A meta-analysis.
PLoS One. 2024;19:e0299715.
- DIMNJAKOVIC J, Buble T, Ivanko P, Poljicanin T, et al
Association of anti-diabetic drugs and covid-19 outcomes in patients with
diabetes mellitus type 2 and chronic kidney disease: Nationwide registry
analysis.
PLoS One. 2024;19:e0301056.
- WANG S, Li J, Zhao Y
Construction and analysis of a network of exercise-induced mitochondria-related
non-coding RNA in the regulation of diabetic cardiomyopathy.
PLoS One. 2024;19:e0297848.
- BAUVIN P, Delacote C, Wandji LCN, Lassailly G, et al
Early prediction of the impact of public health policies on obesity and lifetime
risk of type 2 diabetes: A modelling approach.
PLoS One. 2024;19:e0301463.
Retina
- SU T, Lai D, Wu Y, Gu C, et al
COMPARISON OF THE EFFICACY AND SAFETY OF RANIBIZUMAB 0.5 MG VERSUS 1.0 MG WITH
PARS PLANA VITRECTOMY FOR THE TREATMENT OF PROLIFERATIVE DIABETIC RETINOPATHY: A
Randomized Controlled Trial.
Retina. 2024;44:680-688.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016